Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

31.62
-0.4700-1.46%
Post-market: 31.620.00000.00%19:51 EDT
Volume:1.71M
Turnover:54.73M
Market Cap:3.97B
PE:-22.10
High:33.00
Open:32.09
Low:31.37
Close:32.09
52wk High:41.14
52wk Low:10.83
Shares:125.46M
Float Shares:109.51M
Volume Ratio:1.28
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.59
PE(LYR):-20.66

Loading ...

Dec 19, 2023

Correspondence

Form CORRESP - Correspondence
Dec 11, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 18, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities